Eva Drnovsek

Eva Drnovsek

Auto-generated profile, based on publicly available information

Eva Drnovsek

Smell and Taste Clinic, Department of Otorhinolaryngology Technische Universität Dresden Dresden Germany

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2024 in Parkinsonism & Related Disorders
Verified
Journal Article
Open access
EDEva Drnovsek
Eva Drnovsek
Alexandra ParichenkoAlexandra Parichenko
Alexandra Parichenko
NGNicole Power Guerra
Nicole Power Guerra
JPJulia Pabst
Julia Pabst
KWKristof Wunderlich
Kristof Wunderlich
THThomas Hummel
Thomas Hummel
Patients with Parkinson's Disease (PD) have a distinctive body odor, which was first described by a patient's wife as musky and strong. Later analysis of sebum of patients with PD revealed four volatile organic compounds (VOC) (perillic aldehyde, hippuric acid, eicosane, octadecanal), that differed from healthy subjects, and the patient's wife confirmed that three of them smelled like patients with PD. However, it is unclear whether other people can also perceive this PD body odor and whether it can be artificially recreated. Hence, we aimed to systematically assess whether young women can perceive the PD body odor and whether they can discriminate between the PD body odor and the "artificial PD odor" composed of the four VOCs mentioned above. T-shirts were collected from 19 people with idiopathic PD and 15 age- and gender-matched healthy participants to represent the PD body odor and the healthy body odor, respectively. The four VOCs were diluted in 1,2-propanediol to prepare the artificial PD body odor. Body odors were rated by 26 young women. PD body odor was perceived as more musty, strong, smelly, and unpleasant compared to healthy and artificial PD body odor. Furthermore, around 80 % of women were able to discriminate PD body odor from artificial PD body odor. Overall, this study confirmed a distinctive body odor quality of patients with PD, which can be perceived by young women. However, the four VOCs, composing the artificial PD body odor, were insufficient to reproduce the body odor from PD patients.

1 January 2023 in Chemical Senses
Verified
Journal Article
Closed access
PDF file
EDEva Drnovsek
Eva Drnovsek
MRMaria Rommel
Maria Rommel
Antonie Louise BierlingAntonie Louise Bierling
Antonie Louise Bierling
ACAlexander Croy
Alexander Croy
ICIlona Croy
Ilona Croy
THThomas Hummel
Thomas Hummel
The sense of smell is based on sensory detection of the molecule(s), which is then further perceptually interpreted. A possible measure of olfactory perception is an odor-independent olfactory perceptual fingerprint (OPF) defined by Snitz et al. We aimed to investigate whether OPF can distinguish patients with olfactory dysfunction (OD) due to coronavirus disease (COVID-19) from controls and which perceptual descriptors are important for that separation. Our study included 99 healthy controls and 41 patients. They rated 10 odors using 8 descriptors such as “pleasant,” “intense,” “familiar,” “warm,” “cold,” “irritating,” “edible,” and “disgusting.” An unsupervised machine learning method, hierarchical cluster analysis, showed that OPF can distinguish patients from controls with an accuracy of 83%, a sensitivity of 51%, and a specificity of 96%. Furthermore, a supervised machine learning method, random forest classifier, showed that OPF can distinguish patients and controls in the testing dataset with an accuracy of 86%, a sensitivity of 64%, and a specificity of 96%. Principal component analysis and random forest classifier showed that familiarity and intensity were the key qualities to explain the variance of the data. In conclusion, people with COVID-19-related OD have a fundamentally different olfactory perception.

13 January 2025 in European Journal of Neuroscience
Verified
Journal Article
Open access
EDEva Drnovsek
Eva Drnovsek
KWKristina Weitkamp
Kristina Weitkamp
VMVenkatesh N. Murthy
Venkatesh N. Murthy
EGEdanur Gurbuz
Edanur Gurbuz
AHAntje Haehner
Antje Haehner
THThomas Hummel
Thomas Hummel
Target odorant detection in mixtures has been shown to become more difficult as the number of background odorants increases and falls below chance level in mixtures with 16 components. Our aim was to investigate target odorant detection in mixtures among healthy people and compare it between dysosmic patients and age‐ and gender‐matched controls. Participants underwent extensive olfactory testing and performed two target odorant detection tasks. Eugenol (‘clove’) and phenylethanol (PEA, ‘rose’) were target odorants for all participants, whereas a third target was randomised. For each target odorant in task one (task two), there were four steps. Mixtures contained two (three) odorants in the first step and up to seven (eight) odorants in the fourth step. In each step, participants were asked to choose the sample with the target odorant from the three (two) jars presented. The study included 90 healthy people and 40 patients. As expected, probability of successful target odorant detection decreased as the number of odorants in the mixture increased. However, even when there were seven (eight) odorants in the mixture, around 50% (50%) of healthy people detected Eugenol and around 30% (40%) detected PEA. Furthermore, both distributions of successful target odorant detection differed from the expected binominal distribution of chance (p < 0.001). Patients performed worse at detecting Eugenol or PEA at each step than controls. Furthermore, there were significant positive correlations between task scores and olfactory function. In conclusion, target odorant detection is influenced by the target odorant, number of background odorants, and individual olfactory function.

13 August 2024 in Laryngoscope Investigative Otolaryngology
Verified
Journal Article
Open access
EDEva Drnovsek
Eva Drnovsek
AHAntje Haehner
Antje Haehner
MBMoustafa Bensafi
Moustafa Bensafi
THThomas Hummel
Thomas Hummel
Objective(s): An olfactory perceptual fingerprint (OPF) defines one's olfactory perception using perceptual descriptor ratings (such as odor pleasantness, intensity) for a set of odors. OPFs have been shown to distinguish patients with COVID‐related olfactory dysfunction (OD) and healthy controls with 86% accuracy. However, all participants rated the same odorants. With the aim to evaluate whether the OPFs are indeed odorant independent, previously published dataset by Lötsch et al. was reanalyzed. Furthermore, this independent dataset was used to check whether the OPFs separate patients with OD due to various causes from controls.Methods: The study included 104 controls and 42 patients, who were randomized into four odor sets with 10 odorants each. Odorants were presented using a computer‐controlled olfactometer and evaluated on scales from 1 (not at all) to 5 (very) using perceptual descriptors pleasant, intensive, familiar, edible, irritating, cold/warm, and painful.Results: Permutational multivariate analysis of variance showed that the odor set did not have a significant effect on the OPFs, confirming that the OPFs are indeed odorant independent. On the other hand, both diagnosis and age affected the OPFs (p < .001) and explained around 11% and 5% of the variance of the OPFs, respectively. Furthermore, a supervised machine learning method, random forest classifier, showed that OPF can distinguish patients and controls with 80% accuracy.Conclusion: OPFs are odorant independent. Patients perceived odors as less familiar, less intense, and less edible than controls. Other perceptual descriptors were much less important for the separation of patients and controls.Level of evidence: 3

26 March 2023 in Slovenian Medical Journal
Verified
Journal Article
Open access
PDF file
EDEva Drnovšek
Eva Drnovšek
SDSaša Anžej Doma
Saša Anžej Doma
AKAleša Kristan
Aleša Kristan
Nataša DebeljakNataša Debeljak
Nataša Debeljak
IZIrena Preložnik Zupan
Irena Preložnik Zupan
Erythrocytosis is a condition of increased red cell mass and has a very heterogeneous etiology. Patients may be asymptomatic or have symptoms and signs of increased blood viscosity. A diagnostic algorithm is applied to confirm the precise etiology necessary for appropriate treatment. In the first step, we have to confirm absolute erythrocytosis with hemoglobin (Hb) > 185 g/L and/or hematocrit (Ht) > 0.52 for men and Hb > 165 g/L and/or Ht > 0.48 for women. In the second step, we exclude polycythaemia vera and also search for secondary acquired causes such as lung-, heart- and kidney diseases and tumours with exogenous erythropoietin secretion. It is worth mentioning that according to the WHO guidelines, the diagnosis of polycythaemia vera in patients with an appropriate clinical picture is indicated at lower values, more precisely, Hb > 165 g/L or Ht > 0.49 for men and Hb > 160 g/L or Ht > 0.48 for women. In the third step, we refer patients without a known cause of erythrocytosis for genetic testing to identify congenital erythrocytosis. People in whom we have excluded polycythaemia vera, secondary acquired and congenital erythrocytosis, have idiopathic erythrocytosis. Treatment depends on the cause of the erythrocytosis. Most commonly, it includes acetylsalicylic acid and venipunctures.